Professor of Surgery, Chief Division of Surgical Oncology
UC San Diego
La Jolla, California, United States
Dr. Lowy is Professor of Surgery, Director of Surgical Oncology and Associate Director of Moores Cancer Center at UC San Diego Health. He is a physician-scientist whose clinical and research primarily focuses on identifying and testing novel therapies for pancreatic and appendiceal cancer. His laboratory co-developed the first mouse model of human pancreatic cancer which has become the standard in the field, has been licensed to pharma and used by hundreds of labs worldwide. Dr. Lowy’s research has led to the development and testing of novel therapies which have reached the clinic most recently including reports around a novel antibody-drug conjugate targeting MET positive cells and a tumor penetrating peptide which has advanced from Phase 1 and will now be tested in a randomized Phase 2-3 trials.
Dr. Lowy has served in a number of national leadership roles including the NCI Clinical Trials and Translational Research Committee which advised on development of pancreatic cancer research priorities for the Recalcitrant Cancers Act, serving as vice-chair of the NCI Pancreatic Cancer Task Force, and chair from 2016-2021. He has served as co-leader of the SWOG pancreas cancer subcommittee since 2007. Dr. Lowy serves on the NCCN pancreatic cancer guidelines panel and on advisory boards for PANCAN, The Lustgarten Foundation and The National Pancreas Foundation. Most recently, Dr. Lowy led the creation of the UC-wide Pancreatic Cancer Consortium.